Profoundly incompetent management - Recensione dipendente - Dipendente anonimo presso Bio-Techne

1,0
15 set 2025
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

People outside of management seem decent.

Svantaggi

Let's let facts speak for themselves- Bio-techne bought a company for $275Million in 2018. Somehow they managed to drive that company into the ground- selling it for a whopping $15Million due to close this month! Buy high, sell low. I'd be pissed if I was an investor... Stay far away- this company's leaderhship has absolutely no idea how to run a business. Toxic place, so grateful to be out of that shit-show.

Esplora altre recensioni su Bio-Techne

5,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good benefits, people and hybrid schedule

Svantaggi

Restructuring has it made thing challenging for the businesses

4,0
22 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Manager and coworkers are spectacular.

Svantaggi

Communication from upper management feels very formal and buzz-wordy

Vedi recensioni per: Utile|Valutazione|Data|Tutto